Phase 1 Chronic Spontaneous Urticaria Clinical Trials
2 recruitingPhase 1
What is a Phase 1 trial?
Phase 1 trials test a new treatment in a small group of people for the first time. The primary goal is to evaluate safety, determine a safe dosage range, and identify side effects. These studies typically enroll 20 to 80 participants.
Showing 1–2 of 2 trials
Recruiting
Phase 1
A Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Single and Multiple Doses of EDP-978 in Healthy Adults
Chronic Spontaneous UrticariaChronic Inducible Urticaria
Enanta Pharmaceuticals, Inc98 enrolled1 locationNCT07540910
Recruiting
Phase 1
A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Food Effect of Single and Multiple Doses of HRS-3095 Oral Administration in Healthy Subjects, as Well as the Effect of HRS-3095 on CYP3A4 Metabolic Enzymes
Chronic Spontaneous Urticaria
Chengdu Suncadia Medicine Co., Ltd.66 enrolled1 locationNCT07230418